Enhabit (NYSE:EHAB) Sets New 1-Year High – What’s Next?

Enhabit, Inc. (NYSE:EHAB)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $14.11 and last traded at $14.0840, with a volume of 3908377 shares changing hands. The stock had previously closed at $13.66.

Analyst Ratings Changes

EHAB has been the topic of a number of recent research reports. Truist Financial set a $13.80 target price on shares of Enhabit in a research report on Monday, February 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a research report on Monday, December 29th. Leerink Partners boosted their price objective on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a research note on Monday, February 23rd. Deutsche Bank Aktiengesellschaft upgraded shares of Enhabit to a “buy” rating in a report on Tuesday, January 13th. Finally, TD Cowen reaffirmed a “hold” rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a research note on Friday, March 6th. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $13.57.

Enhabit Stock Performance

The business’s fifty day moving average price is $12.33 and its 200-day moving average price is $10.03. The stock has a market cap of $714.34 million, a PE ratio of -156.49 and a beta of 1.55. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.63 and a current ratio of 1.63.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The firm had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million. As a group, equities research analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Julie Diane Jolley sold 2,793 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This represents a 1.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 3.40% of the company’s stock.

Institutional Trading of Enhabit

A number of hedge funds have recently bought and sold shares of the company. Osaic Holdings Inc. lifted its holdings in Enhabit by 337.5% in the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after acquiring an additional 2,018 shares during the period. State of Alaska Department of Revenue purchased a new position in Enhabit in the third quarter worth about $27,000. Tower Research Capital LLC TRC grew its stake in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after purchasing an additional 2,059 shares during the period. Russell Investments Group Ltd. increased its position in shares of Enhabit by 523.1% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock valued at $56,000 after purchasing an additional 4,865 shares during the last quarter. Finally, Simplex Trading LLC increased its position in shares of Enhabit by 69.8% during the 4th quarter. Simplex Trading LLC now owns 8,115 shares of the company’s stock valued at $75,000 after purchasing an additional 3,336 shares during the last quarter.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.